Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutathione homeostasis refers to the tightly regulated processes of glutathione synthesis, recycling, compartmentalization, and degradation that together maintain optimal intracellular and extracellular glutathione concentrations and redox state. Glutathione, a tripeptide antioxidant, is central to detoxifying reactive oxygen species, maintaining redox balance, and regulating cell fate decisions. Disruptions in glutathione homeostasis are implicated in a wide array of diseases, including cancer, neurodegeneration, and inflammatory disorders. While not a single therapeutic target, multiple proteins—enzymes, transporters, and regulatory factors—govern this crucial process, and modulation of glutathione homeostasis is a therapeutic strategy in specific clinical scenarios.
Modulators may inhibit or stimulate enzymes involved in GSH synthesis or recycling, alter transport, or change cellular redox status via effects on GSH/GSSG ratio. Some drugs induce cell death (e.g., ferroptosis) by depleting GSH or inhibiting its synthesis.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutathione homeostasis (None for "Glutathione homeostasis" (GSH is the abbreviation for glutathione itself)).